Should we recommend earlier prostate cancer screening for Black men, who have a higher risk of prostate cancer mortality? We examine the pros and cons of this question raised by a new study in the New England Journal of Medicine. More
A telehealth company's downfall sheds light on the overprescription of stimulants to ADHD patients More
What's the evidence behind PCI, and why do hospitals keep doing these procedures? We revisit this issue with a look back at research and interviews over last few years to give you the answers. More
In the first year of the Covid-19 pandemic, did hospitals curb unnecessary and potentially harmful services? Watch the video of the roundtable discussion on overuse during Covid-19 to find out! More
Overprescribing of antibiotics for Medicare patients with Covid-19 was rampant in the first year of the pandemic, research from the CDC finds. More
The life expectancy of the average American dropped by 2 years in 2020, but by only a few months in peer countries. This discrepancy gets worse when you adjust for sex, race, and ethnicity. This is despite the fact that the US spends the most money on healthcare in the world. How do we get such poor health outcomes with such high spending? More
As MRI has become a more popular screening tool for women at low or average risk of cancer, researchers caution that one MRI can easily "cascade" into more medical medical services and diagnoses More
Over the past decade, what has the Choosing Wisely program taught us about strategies and obstacles to reducing low-value care? Vikas Saini discusses on the NEJM podcast. More
One of the big selling points of 3D mammograms is their potential to reduce false positive results. However, a new study shows that 3D mammograms don't reduce false positives as much as you would think. More
In America's cancer centers, where many patients go for specialized cancer treatment, prostate screening policies do not always align with evidence-based recommendations. More